Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$29.00
-0.30-1.02%
Last update: Oct 2, 7:59 PM
$29.02
-0.28-0.96%
Hims & Hers Health Inc (HIMS) Stock Price, Quote, News & History
HIMSNYSE
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Hims & Hers Health (NYSE:HIMS) through any online brokerage.
Other companies in Hims & Hers Health’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Quest Diagnostics Inc (NYSE:DGX), Labcorp Holdings Inc (NYSE:LH) and Guardant Health Inc (NASDAQ:GH).
Hims & Hers Health has a consensus price target of $31.07.
The stock price for Hims & Hers Health (NYSE: HIMS) is $29.0201 last updated October 2, 2026 at 7:59 PM EDT.
There are no upcoming dividends for Hims & Hers Health.
Hims & Hers Health does not have any upcoming earnings scheduled.
There is no upcoming split for Hims & Hers Health.
Hims & Hers Health is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.
